Technical Analysis for LYRA - Lyra Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| 50 DMA Resistance | Bearish | -3.71% | |
| Wide Bands | Range Expansion | -3.71% | |
| 20 DMA Resistance | Bearish | -3.98% | |
| 50 DMA Resistance | Bearish | -3.98% | |
| Shooting Star Candlestick | Bearish | -3.98% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -3.98% | |
| Doji - Bearish? | Reversal | -3.98% | |
| Wide Bands | Range Expansion | -3.98% | |
| 50 DMA Resistance | Bearish | -3.89% |
| Alert | Time |
|---|---|
| Down 3% | about 7 hours ago |
| Fell Below Previous Day's Low | about 7 hours ago |
| Down 2 % | about 7 hours ago |
| Fell Below 10 DMA | about 7 hours ago |
| 60 Minute Opening Range Breakdown | about 8 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/10/2024
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions using XTreo technology platform for the localized treatment of patients with ear, nose, and throat diseases. Its XTreo platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210 and LYR-220, which are bioresorbable polymeric matrices for the treatment of chronic rhinosinusitis. Lyra Therapeutics, Inc. was founded in 2005 and is headquartered in Watertown, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Sinus Headache Chronic Rhinosinusitis Sinusitis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Sinus Headache Chronic Rhinosinusitis Sinusitis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.79 |
| 52 Week Low | 1.945 |
| Average Volume | 395,362 |
| 200-Day Moving Average | 4.25 |
| 50-Day Moving Average | 5.50 |
| 20-Day Moving Average | 5.59 |
| 10-Day Moving Average | 5.30 |
| Average True Range | 0.39 |
| RSI (14) | 42.20 |
| ADX | 12.15 |
| +DI | 19.00 |
| -DI | 17.50 |
| Chandelier Exit (Long, 3 ATRs) | 5.63 |
| Chandelier Exit (Short, 3 ATRs) | 6.10 |
| Upper Bollinger Bands | 6.51 |
| Lower Bollinger Band | 4.68 |
| Percent B (%b) | 0.28 |
| BandWidth | 32.62 |
| MACD Line | -0.11 |
| MACD Signal Line | -0.07 |
| MACD Histogram | -0.0366 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.73 | ||||
| Resistance 3 (R3) | 5.77 | 5.62 | 5.64 | ||
| Resistance 2 (R2) | 5.62 | 5.49 | 5.61 | 5.61 | |
| Resistance 1 (R1) | 5.41 | 5.40 | 5.34 | 5.37 | 5.58 |
| Pivot Point | 5.26 | 5.26 | 5.23 | 5.25 | 5.26 |
| Support 1 (S1) | 5.05 | 5.13 | 4.98 | 5.01 | 4.80 |
| Support 2 (S2) | 4.90 | 5.04 | 4.89 | 4.77 | |
| Support 3 (S3) | 4.69 | 4.90 | 4.74 | ||
| Support 4 (S4) | 4.65 |
